Delivery Order SPE2DB20D2104-SPE2DB24FT75E
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $5.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $58,480.00 firm fixed-price delivery order is for the supply of 4563469535 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a completion date of January 30, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,726.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of 4,563,415,015 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a period of performance through January 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $78,664.00 fixed-price delivery order is for the procurement of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of January 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $2,965.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a completion date of February 15, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,200.64 delivery order is for the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, and has a completion date of January 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,681.55 delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a total ceiling value of $1,720.84 and covers the delivery of 4,562,894,521 vials of the TYPHIM VI 25 MCG/0.5 ML vaccine. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,388.60, is for the delivery of 4,566,414,295 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. This is a firm-fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,034.55 firm-fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award has an ultimate completion date of January 9, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $18,924.08, is for the delivery of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. It is a firm fixed-price delivery order contract with a completion date of December 12, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...